- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 13, 2020
Clinical News
Adaptimmune rises on early promise for SPEAR TCR cell therapies in solid tumors
BioCentury | Aug 22, 2019
Emerging Company Profile
Tscan: Tracking down novel T cell targets
Tscan is finding novel TCR-antigen pairs with its peptidome screening platform
BioCentury | Aug 2, 2019
Clinical News
Aug. 2 Clinical Quick Takes: AB Sciences halts metastatic melanoma program; plus NIH, Adaptimmune and more
BioCentury | Oct 26, 2018
Clinical News
Adaptimmune reports zero responses across three T cell therapy trials
BioCentury | Oct 22, 2018
Clinical News
Adaptimmune reports zero responses across three T cell therapy trials
BioCentury | Sep 8, 2017
Company News
GSK exercises option for Adaptimmune’s NY-ESO SPEAR T cell therapy program
BioCentury | Jul 20, 2017
Product R&D
Eureka moment for TCR mimics
How Eureka is developing high affinity TCR-like antibodies
Items per page:
1 - 10 of 12